|
US4570630A
(en)
*
|
1983-08-03 |
1986-02-18 |
Miles Laboratories, Inc. |
Medicament inhalation device
|
|
US5161524A
(en)
*
|
1991-08-02 |
1992-11-10 |
Glaxo Inc. |
Dosage inhalator with air flow velocity regulating means
|
|
US6582728B1
(en)
*
|
1992-07-08 |
2003-06-24 |
Inhale Therapeutic Systems, Inc. |
Spray drying of macromolecules to produce inhaleable dry powders
|
|
GB9216038D0
(en)
*
|
1992-07-28 |
1992-09-09 |
Bespak Plc |
Dispensing apparatus for powdered medicaments
|
|
WO1994020164A1
(fr)
*
|
1993-03-03 |
1994-09-15 |
Glaxo Wellcome Inc. |
Support de medicament en poudre, pour inhalateur
|
|
US5388572A
(en)
*
|
1993-10-26 |
1995-02-14 |
Tenax Corporation (A Connecticut Corp.) |
Dry powder medicament inhalator having an inhalation-activated piston to aerosolize dose and deliver same
|
|
US5388573A
(en)
*
|
1993-12-02 |
1995-02-14 |
Tenax Corporation |
Dry powder inhalator medicament carrier
|
|
US5505194A
(en)
*
|
1994-03-23 |
1996-04-09 |
Abbott Laboratories |
Aerosol inhalation device having slideably and rotatably connected elliptical cylinder portions
|
|
US6290991B1
(en)
|
1994-12-02 |
2001-09-18 |
Quandrant Holdings Cambridge Limited |
Solid dose delivery vehicle and methods of making same
|
|
FR2731911B1
(fr)
*
|
1995-03-20 |
1997-08-14 |
Paul Seyvos |
Dispositif qui permet d'inhaler, par la bouche, l' odeur de produits contenus dans un reservoir a des fins therapeutiques
|
|
US6182655B1
(en)
|
1995-12-07 |
2001-02-06 |
Jago Research Ag |
Inhaler for multiple dosed administration of a pharmacological dry powder
|
|
US7131441B1
(en)
|
1995-12-07 |
2006-11-07 |
Skyepharma Ag |
Inhaler for multiple dosed administration of a pharmacological dry powder
|
|
US5669378A
(en)
*
|
1995-12-21 |
1997-09-23 |
Pera; Ivo |
Inhaling device
|
|
US20030203036A1
(en)
|
2000-03-17 |
2003-10-30 |
Gordon Marc S. |
Systems and processes for spray drying hydrophobic drugs with hydrophilic excipients
|
|
CA2212430A1
(fr)
*
|
1997-08-07 |
1999-02-07 |
George Volgyesi |
Appareil inhalateur
|
|
UA73924C2
(en)
*
|
1998-10-09 |
2005-10-17 |
Nektar Therapeutics |
Device for delivering active agent formulation to lungs of human patient
|
|
DE29908593U1
(de)
|
1999-05-14 |
1999-07-22 |
Jago Research AG, Hergiswil |
Mundstück für einen Inhalator zur Abgabe eines Medikaments
|
|
PL204106B1
(pl)
|
2000-02-28 |
2009-12-31 |
Pharmakodex Ltd |
Zestaw do dostarczania środka terapeutycznego
|
|
US6595210B2
(en)
*
|
2000-11-27 |
2003-07-22 |
Unisia Jecs Corporation |
Inhalator for administering powder composition
|
|
GB2380410B
(en)
*
|
2001-10-05 |
2003-11-19 |
Alchemy Healthcare Ltd |
Apparatus for the nasal or oral delivery of a medicament
|
|
WO2003078448A1
(fr)
|
2002-03-13 |
2003-09-25 |
Signum Biosciences, Inc. |
Modulation de la methylation de proteines et du phosphate des phosphoproteines
|
|
ITMO20020297A1
(it)
*
|
2002-10-16 |
2004-04-17 |
Roberto Oliva |
Inalatore per preparati monodose in capsule.
|
|
US20060045849A1
(en)
*
|
2004-08-24 |
2006-03-02 |
Farhan Taghizadeh |
Method of customizing the fragrance of nasal medications
|
|
PL370285A1
(pl)
*
|
2004-09-23 |
2006-04-03 |
Glaxosmithkline Pharmaceuticals Spółka Akcyjna |
Inhalator proszkowy
|
|
US7923041B2
(en)
|
2005-02-03 |
2011-04-12 |
Signum Biosciences, Inc. |
Compositions and methods for enhancing cognitive function
|
|
WO2006084033A1
(fr)
|
2005-02-03 |
2006-08-10 |
Signum Biosciences, Inc. |
Compositions et procedes pour l'amelioration de la fonction cognitive
|
|
US9345745B2
(en)
*
|
2005-04-29 |
2016-05-24 |
Bo Wang |
Methods for treating inflammatory disorders and traumatic brain injury using stabilized non-hematopoietic EPO short peptides
|
|
WO2007052154A2
(fr)
|
2005-04-29 |
2007-05-10 |
University Of Medicine And Dentistry Of New Jersey |
Peptide court derive d'erythropoietine et ses mimetiques utilises comme modulateurs immuno / inflammatoires
|
|
US9585932B2
(en)
|
2005-04-29 |
2017-03-07 |
Peter C. Dowling |
Use of EPO-derived peptide fragments for the treatment of neurodegenerative disorders
|
|
WO2007024876A2
(fr)
*
|
2005-08-24 |
2007-03-01 |
The Board Of Trustees Of Leland Stanford Junior University |
Methodes de traitement et de surveillance de l'inflammation et du desequilibre d'oxydoreduction dans la mucoviscidose
|
|
US20090192227A1
(en)
*
|
2005-08-24 |
2009-07-30 |
Rabindra Tirouvanziam |
N-Acetylcysteine Compositions and Methods for Treating Acute Exacerbations of Inflammatory Lung Disease
|
|
US8227408B2
(en)
*
|
2005-09-07 |
2012-07-24 |
Neurotez, Inc. |
Leptin as an anti-amyloidogenic biologic and methods for delaying the onset and reducing Alzheimer's disease-like pathology
|
|
US9107824B2
(en)
|
2005-11-08 |
2015-08-18 |
Insmed Incorporated |
Methods of treating cancer with high potency lipid-based platinum compound formulations administered intraperitoneally
|
|
GB0604444D0
(en)
|
2006-03-06 |
2006-04-12 |
Optinose As |
Nasal devices
|
|
AU315526S
(en)
|
2006-09-28 |
2007-08-03 |
Glaxo Group Ltd |
Inhalation device
|
|
ES2594281T3
(es)
|
2007-01-10 |
2016-12-19 |
Purdue Research Foundation |
Inhibidores polipeptídicos de HSP27 quinasa y usos de los mismos
|
|
DK2185698T3
(en)
*
|
2007-08-07 |
2015-07-27 |
Purdue Research Foundation |
Kinase Inhibitors and Uses thereof
|
|
CN101980738A
(zh)
|
2008-02-07 |
2011-02-23 |
华盛顿大学 |
圆周气雾设备
|
|
KR20110028457A
(ko)
*
|
2008-05-21 |
2011-03-18 |
뉴로테즈 인코포레이티드 |
신경섬유 매듭과 연관된 신경변성 장애를 치료하는 방법
|
|
MY155524A
(en)
*
|
2008-06-13 |
2015-10-30 |
Mannkind Corp |
A dry powder inhaler and system for drug delivery
|
|
CN102256613B
(zh)
*
|
2008-10-20 |
2014-09-10 |
莫伊莱麦屈克斯公司 |
用于治疗或者预防粘连的多肽
|
|
CA2742600A1
(fr)
*
|
2008-11-04 |
2010-05-14 |
Nikolaos Tezapsidis |
Compositions a base de leptine et methodes de traitement de troubles evolutifs de la fonction cognitive provoques par une accumulation d'enchevetrements neurofibrillaires et de beta-amyloide
|
|
US9327008B2
(en)
*
|
2008-12-10 |
2016-05-03 |
Purdue Research Foundation |
Cell-permeant peptide-based inhibitor of kinases
|
|
WO2011011721A2
(fr)
|
2009-07-24 |
2011-01-27 |
Amazentis Sa |
Composés, compositions et méthodes de protection de la santé du cerveau en cas de troubles neurodégénératifs
|
|
US9890195B2
(en)
*
|
2009-07-27 |
2018-02-13 |
Purdue Research Foundation |
MK2 inhibitor compositions and methods to enhance neurite outgrowth, neuroprotection, and nerve regeneration
|
|
EP2680913B1
(fr)
|
2011-03-03 |
2020-05-06 |
Impel NeuroPharma Inc. |
Dispositif d'administration de médicament par voie nasale
|
|
CN108014340A
(zh)
|
2011-04-12 |
2018-05-11 |
莫伊莱麦屈克斯公司 |
用于预防或治疗以成纤维细胞异常增殖及细胞外基质沉积为特征的疾病的组合物和方法
|
|
US9890200B2
(en)
|
2011-04-12 |
2018-02-13 |
Moerae Matrix, Inc. |
Compositions and methods for preventing or treating diseases, conditions, or processes characterized by aberrant fibroblast proliferation and extracellular matrix deposition
|
|
US9579337B2
(en)
|
2011-04-25 |
2017-02-28 |
Cornell University |
Use of uridine and deoxyuridine to treat folate-responsive pathologies
|
|
CN107376071B
(zh)
|
2011-05-09 |
2021-07-09 |
英倍尔药业股份有限公司 |
用于将化合物递送到使用者的上部嗅觉区的喷嘴
|
|
EP2589381B1
(fr)
|
2011-11-04 |
2016-08-31 |
Rabindra Tirouvanziam |
Compositions pour améliorer ou préserver une fonction de poumons chez un patient souffrant de troubles pulmonaires
|
|
WO2013134636A1
(fr)
|
2012-03-09 |
2013-09-12 |
Purdue Research Foundation |
Compositions et procédés d'administration de peptides inhibiteurs de kinases
|
|
EP2892524B1
(fr)
|
2012-09-04 |
2020-11-25 |
Eleison Pharmaceuticals, LLC |
Prévention de la rechute du cancer pulmonaire avec un complexe lipide/cisplatine
|
|
HK1222358A1
(zh)
|
2013-04-28 |
2017-06-30 |
Impel Neuropharma Inc. |
医用单位剂量容器
|
|
WO2015006639A1
(fr)
|
2013-07-12 |
2015-01-15 |
SILVA, John, H. |
Pièce buccale pour inhalateur
|
|
RU2727516C2
(ru)
|
2013-09-10 |
2020-07-22 |
Борд Оф Риджентс Оф Дзе Юниверсити Оф Техас Систем |
Терапевтические средства, нацеленные на укороченные белки аденоматозного полипоза толстого кишечника (арс)
|
|
US10336788B2
(en)
|
2014-04-17 |
2019-07-02 |
Moerae Matrix, Inc. |
Inhibition of cardiac fibrosis in myocardial infarction
|
|
USD748242S1
(en)
|
2014-07-11 |
2016-01-26 |
H. Stuart Campbell |
Inhaler mouthpiece
|
|
US10082496B2
(en)
|
2014-09-10 |
2018-09-25 |
Board Of Regents Of The University Of Texas System |
Targeting emopamil binding protein (EBP) with small molecules that induce an abnormal feedback response by lowering endogenous cholesterol biosynthesis
|
|
MX2017006372A
(es)
|
2014-11-17 |
2017-08-21 |
Moerae Matrix Inc |
Composiciones y metodos para prevenir o tratar enfermedades, condiciones o procesos caracterizados por proliferacion de fibroblasto aberrante y matrix extracelular.
|
|
ES2796973T3
(es)
|
2014-12-10 |
2020-11-30 |
Hyperstem Sa |
Métodos y composiciones para reducir el crecimiento, la migración y la invasividad de células madre de cáncer cerebral y mejorar la supervivencia de pacientes con tumores cerebrales
|
|
KR20170102900A
(ko)
|
2015-01-08 |
2017-09-12 |
모레 매트릭스 인코포레이티드 |
Mk2 저해제 펩타이드의 제형
|
|
CA2978941A1
(fr)
|
2015-03-12 |
2016-09-15 |
Moerae Matrix, Inc. |
Utilisation de compositions contenant un peptide inhibiteur de mk2 pour traiter un cancer du poumon non a petites cellules avec celles-ci
|
|
EP3307069B1
(fr)
|
2015-06-10 |
2021-08-04 |
Hackensack University Medical Center |
Utilisation du telmisartan pour la prévention et le traitement de la maladie du greffon contre l'hôte et d'autres maladies auto-immunes et allo-immunes
|
|
WO2017007634A1
(fr)
|
2015-07-06 |
2017-01-12 |
The Board Of Regents Of The University Of Texas System |
Composés benzamide ou benzamine à utiliser en tant qu'anticancéreux pour le traitement de cancers humains
|
|
EP3322417B1
(fr)
|
2015-07-15 |
2023-08-23 |
The Board of Regents of The University of Texas System |
Ciblage de protéine de liaison de l'emopamil (ebp) avec de petites molécules qui induisent une réponse de rétroaction anormale par l'abaissement de la biosynthèse du cholestérol endogène
|
|
EP3341059B1
(fr)
|
2015-09-10 |
2022-03-02 |
Impel NeuroPharma Inc. |
Dispositif d'administration nasale en ligne
|
|
JP6953414B2
(ja)
|
2016-01-20 |
2021-10-27 |
フラリー パウダーズ エルエルシーＦｌｕｒｒｙ Ｐｏｗｄｅｒｓ，Ｌｌｃ |
親油性成分を含む吸入に好適な分散性の噴霧乾燥粉末を製造する方法
|
|
US11833118B2
(en)
|
2016-01-20 |
2023-12-05 |
Flurry Powders, Llc |
Encapsulation of lipophilic ingredients in dispersible spray dried powders suitable for inhalation
|
|
US11571532B2
(en)
|
2017-11-21 |
2023-02-07 |
Impel Pharmaceuticals Inc. |
Intranasal device with dip tube
|
|
US11395887B2
(en)
|
2017-11-21 |
2022-07-26 |
Impel Pharmaceuticals Inc. |
Intranasal device with inlet interface
|
|
EP3735223A4
(fr)
|
2018-01-05 |
2021-10-13 |
Impel Neuropharma Inc. |
Administration intranasale d'olanzapine par un dispositif olfactif de précision
|
|
BR112020013744A8
(pt)
|
2018-01-05 |
2022-10-18 |
Impel Neuropharma Inc |
Dispensação intranasal de di-hidroergotamina por dispositivo olfativo de precisão
|
|
JP2021532098A
(ja)
|
2018-07-19 |
2021-11-25 |
インペル ニューロファーマ インコーポレイテッド |
パーキンソン病の治療のためのレボドパおよびドーパデカルボキシラーゼ阻害剤の呼吸管路送達
|
|
CN113473967B
(zh)
|
2019-01-03 |
2022-09-09 |
英倍尔制药公司 |
经鼻药物递送装置
|
|
AU2020277313A1
(en)
|
2019-05-17 |
2022-01-20 |
Impel Pharmaceuticals Inc. |
Single-use nasal delivery device
|